Total Payments
$20,140
2024 Payments
$6,549
Companies
73
Transactions
747
Medicare Patients
2,681
Medicare Billing
$378,025
Payment Breakdown by Category
Food & Beverage$17,440 (86.6%)
Other$1,440 (7.2%)
Consulting$1,260 (6.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,440 | 745 | 86.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,440 | 1 | 7.2% |
| Consulting Fee | $1,260 | 1 | 6.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $2,358 | 53 | $0 (2024) |
| Janssen Biotech, Inc. | $1,492 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,143 | 47 | $0 (2024) |
| Incyte Corporation | $1,029 | 45 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,010 | 57 | $0 (2024) |
| Celgene Corporation | $899.90 | 44 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $828.82 | 49 | $0 (2024) |
| Merck Sharp & Dohme LLC | $746.16 | 21 | $0 (2024) |
| Amgen Inc. | $690.98 | 28 | $0 (2023) |
| Genentech USA, Inc. | $636.38 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,549 | 235 | PFIZER INC. ($1,792) |
| 2023 | $5,960 | 209 | Janssen Biotech, Inc. ($1,344) |
| 2022 | $3,570 | 165 | Celgene Corporation ($345.80) |
| 2021 | $2,415 | 103 | Amgen Inc. ($276.96) |
| 2020 | $201.72 | 10 | Daiichi Sankyo Inc. ($22.45) |
| 2019 | $355.51 | 12 | Servier Pharmaceuticals LLC ($121.90) |
| 2018 | $714.77 | 10 | Exelixis Inc. ($256.40) |
| 2017 | $374.12 | 3 | Merck Sharp & Dohme Corporation ($251.06) |
All Payment Transactions
747 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Coherus Biosciences Inc. | LOQTORZI (Biological) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Oncology | ||||||
| 12/23/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Oncology | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: BioOncology | ||||||
| 12/17/2024 | Immunocore Limited | KIMMTRAK (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Oncology | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $25.63 | General |
| Category: Oncology | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $0.44 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $21.01 | General |
| Category: Hematology | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $32.02 | General |
| Category: Oncology | ||||||
| 12/07/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $1.12 | General |
| Category: Oncology | ||||||
| 12/06/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $24.64 | General |
| Category: Hematology/Oncology | ||||||
| 12/04/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $0.97 | General |
| Category: Hematology/Oncology | ||||||
| 12/02/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug), Somatuline Depot | Food and Beverage | In-kind items and services | $30.26 | General |
| Category: Oncology | ||||||
| 11/25/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: ONCOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $1.51 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Oncology | ||||||
| 11/21/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $23.10 | General |
| 11/19/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $20.75 | General |
| Category: Hematology | ||||||
| 11/19/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Oncology | ||||||
| 11/19/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $1.31 | General |
| Category: Hematology | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $30.11 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 756 | 2,209 | $365,452 | $87,468 |
| 2022 | 27 | 992 | 7,053 | $488,793 | $144,999 |
| 2021 | 24 | 915 | 10,638 | $344,532 | $143,039 |
| 2020 | 1 | 18 | 26 | $6,240 | $2,519 |
Total Patients
2,681
Total Services
19,926
Medicare Billing
$378,025
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 450 | $189,058 | $44,424 | 23.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 24 | 90 | $42,333 | $9,799 | 23.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 69 | 148 | $36,594 | $9,745 | 26.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 29 | $16,499 | $4,068 | 24.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 22 | $13,002 | $3,140 | 24.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $12,300 | $2,495 | 20.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 15 | 42 | $9,651 | $2,240 | 23.2% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 20 | 69 | $7,047 | $1,571 | 22.3% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 20 | 52 | $5,991 | $1,549 | 25.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $7,640 | $1,430 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 19 | $5,314 | $1,380 | 26.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 45 | 126 | $4,497 | $1,304 | 29.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 56 | 166 | $4,369 | $1,263 | 28.9% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 17 | 76 | $3,344 | $863.25 | 25.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 74 | $3,550 | $773.14 | 21.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 40 | 81 | $1,247 | $680.40 | 54.6% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 93 | 128 | $2,131 | $514.80 | 24.2% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2023 | 29 | 182 | $704.80 | $182.26 | 25.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 23 | 363 | $122.27 | $31.79 | 26.0% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 20 | 61 | $59.26 | $15.16 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 167 | 521 | $181,958 | $53,293 | 29.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 16 | 1,027 | $52,345 | $17,419 | 33.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 28 | 129 | $53,377 | $15,612 | 29.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 79 | 198 | $36,490 | $11,882 | 32.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 53 | 61 | $31,714 | $10,050 | 31.7% |
About Dr. Sungwon Kyung, M.D
Dr. Sungwon Kyung, M.D is a Hematology & Oncology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2014. The National Provider Identifier (NPI) number assigned to this provider is 1831501840.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sungwon Kyung, M.D has received a total of $20,140 in payments from pharmaceutical and medical device companies, with $6,549 received in 2024. These payments were reported across 747 transactions from 73 companies. The most common payment nature is "Food and Beverage" ($17,440).
As a Medicare-enrolled provider, Kyung has provided services to 2,681 Medicare beneficiaries, totaling 19,926 services with total Medicare billing of $378,025. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Los Angeles, CA
- Active Since 05/24/2014
- Last Updated 07/02/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1831501840
Products in Payments
- IBRANCE (Drug) $1,814
- RYBREVANT (Drug) $1,356
- KEYTRUDA (Biological) $746.16
- OPDIVO (Biological) $725.82
- JAKAFI (Drug) $691.16
- CALQUENCE (Drug) $478.60
- SARCLISA (Biological) $468.54
- Enhertu (Drug) $432.47
- MONJUVI (Drug) $414.27
- XPOVIO (Drug) $410.13
- REBLOZYL (Biological) $345.39
- TUKYSA (Drug) $326.07
- Lenvima (Drug) $325.61
- Cabometyx (Drug) $314.72
- CABOMETYX (Drug) $310.68
- TABRECTA (Drug) $294.68
- Pomalyst (Drug) $238.21
- LUMAKRAS (Drug) $232.94
- Xospata (Drug) $218.22
- OPDUALAG (Drug) $217.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Los Angeles
Dennis Slamon, Md, MD
Hematology & Oncology — Payments: $4.3M
Hematology & Oncology $4.3M
George Yaghmour
Hematology & Oncology — Payments: $1.6M
Hematology & Oncology $1.6M
Dr. Robert Vescio, M.d, M.D
Hematology & Oncology — Payments: $1.4M
Hematology & Oncology $1.4M
Dr. Kevin Kelly, M.d, M.D
Hematology & Oncology — Payments: $1.1M
Hematology & Oncology $1.1M
David Berz, Md, Phd, Mph, MD, PHD, MPH
Hematology & Oncology — Payments: $613,380
Hematology & Oncology $613,380
Raghuveer Ranganathan, M.d, M.D
Hematology & Oncology — Payments: $472,334
Hematology & Oncology $472,334